Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Authors
Keywords
-
Journal
CELL
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-10
DOI
10.1016/j.cell.2021.02.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop
- (2020) Javier A. Jaimes et al. JOURNAL OF MOLECULAR BIOLOGY
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- (2020) Fatima Amanat et al. NATURE MEDICINE
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies
- (2020) Claudia P. Arevalo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- SARS-CoV-2 seroprevalence among parturient women in Philadelphia
- (2020) Dustin D. Flannery et al. Science Immunology
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
- (2020) Phuong Nguyen-Contant et al. mBio
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility
- (2020) Sigrid Gouma et al. Nature Communications
- Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
- (2020) Daniel Poston et al. CLINICAL INFECTIOUS DISEASES
- Recent endemic coronavirus infection is associated with less-severe COVID-19
- (2020) Manish Sagar et al. JOURNAL OF CLINICAL INVESTIGATION
- Human coronavirus circulation in the United States 2014–2017
- (2018) Marie E. Killerby et al. JOURNAL OF CLINICAL VIROLOGY
- Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1
- (2018) Nehemya Friedman et al. Viruses-Basel
- Immune history and influenza virus susceptibility
- (2017) Sarah Cobey et al. Current Opinion in Virology
- The dominance of human coronavirus OC43 and NL63 infections in infants
- (2011) Ronald Dijkman et al. JOURNAL OF CLINICAL VIROLOGY
- Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method
- (2010) E. R. Gaunt et al. JOURNAL OF CLINICAL MICROBIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started